psilocybin

Will microdosing become a new norm?

In May of this year, Fast Company reported employees at the mushroom coffee brand MUD\WTR added small amounts of hallucinogenic (psilocybin) mushrooms to their morning brew. Silicon Valley employees have long been rumoured to microdose psychedelics at work to enhance focus, creativity, and improve productivity. The popularity of microdosing has since grown among politicians and …

Will microdosing become a new norm? Read More »

Using psychedelics to treat opioid use disorder

Opioids are prescription medications or street drugs derived from the opium poppy plant. Opioid use disorder (OUD) is a mental disorder that involves the harmful use of opioids or dependence on them. Symptoms may include a strong desire or difficulty in controlling use, persistent use despite harmful consequences, or physical withdrawal states. Opioid use in …

Using psychedelics to treat opioid use disorder Read More »

Madrigal Mental Care Develops Psychedelic Drug Treatment for Post-Traumatic Stress Disorder

Novel Nasal-Spray Nano-Formulation Enables Nose-To-Brain Delivery of Biodegradable Nanoparticles that can Encapsulate Psychedelic Substances such as Psilocybin Madrigal Mental Care, a biopharmaceutical company developing a breakthrough delivery system for psychedelic drugs, introduced its novel nanotechnology for the treatment and prevention of post-traumatic stress disorder (PTSD) at Biomed Israel 2022, the premier international Life Science and …

Madrigal Mental Care Develops Psychedelic Drug Treatment for Post-Traumatic Stress Disorder Read More »

Studies show psilocybin therapy has potential for anorexia nervosa and severe treatment-resistant depression

Positive Early Signals Seen in Two Investigator-Initiated Studies Presented at the Society of Biological Psychiatry Annual Meeting in New Orleans COMPASS Pathways (COMPASS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced that positive data two investigator-initiated studies demonstrating the potential of COMP360 psilocybin therapy in anorexia …

Studies show psilocybin therapy has potential for anorexia nervosa and severe treatment-resistant depression Read More »

New Study Explores Relationship Between Psychedelics and Consciousness

Psychedelic drugs, like psilocybin, an ingredient found in so-called magic mushrooms, have shown promise in treating a range of addictions and mental health disorders. Yet, there’s something mysterious and almost mystical about their effects, and they are commonly believed to provide unique insights into the nature of consciousness. Now, a new study by Johns Hopkins …

New Study Explores Relationship Between Psychedelics and Consciousness Read More »

LSD: A Future Anti-Anxiety Pill?

New Study by Dr. Gabriella Gobbi Reveals the Neurobiological Mechanisms by which LSD could Relieve Anxiety The craze for psychedelics used for therapeutic purposes is real. However, the scientific evidence supporting their effectiveness and explaining their mode of action in treating mental health disorders is still very thin. A new study led by Dr. Gabriella …

LSD: A Future Anti-Anxiety Pill? Read More »

The Potential Role of Psychedelics in Cancer Treatment

Psilocybin shown to aid in cancer-related mental health conditions Cancer is a modern chronic disease characterized by abnormal cells dividing uncontrollably. There are over 200 types of cancer, some of which may spread into other body tissues.  Cancer is the leading cause of death in Canada, responsible for over 28 percent of all deaths. Researchers …

The Potential Role of Psychedelics in Cancer Treatment Read More »

Study Shows Psilocybin Treatment for Major Depression Effective for Up to a Year for Most Patients

Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month. Now, in a follow-up study of those participants, the researchers report that the substantial antidepressant effects of psilocybin-assisted therapy, given with supportive psychotherapy, may last at least a year for some patients. …

Study Shows Psilocybin Treatment for Major Depression Effective for Up to a Year for Most Patients Read More »

Monash University-Led Team Receives Funding for Psychedelic Psychotherapy in Treatment-Resistant Depression

The Medical Research Future Fund Clinical Trials Activity Initiative has awarded $2.7M for Innovative Therapies for Mental Illness to a Monash University-led team, to evaluate the efficacy of psilocybin-assisted psychotherapy in treatment-resistant depression. Major Depressive Disorder (MDD) is, sadly, common, and results in the greatest global burden of disease. Although there are established treatments for …

Monash University-Led Team Receives Funding for Psychedelic Psychotherapy in Treatment-Resistant Depression Read More »

Scroll to Top